-
1
-
-
2442709008
-
-
Japanese source
-
-
-
-
2
-
-
2442712695
-
-
Japanese source
-
-
-
-
3
-
-
0031009846
-
Fixed Drug Eruption Caused by lopamidol, A Contrast Medium
-
Yamauchi R, Morita A, Tsuji T: Fixed Drug Eruption Caused by lopamidol, A Contrast Medium. J Dermatol 24: 243-245, 1997
-
(1997)
J Dermatol
, vol.24
, pp. 243-245
-
-
Yamauchi, R.1
Morita, A.2
Tsuji, T.3
-
4
-
-
0025082278
-
Transient, Nonpigmenting fixed drug eruption caused by radiopaque contrast media
-
Benson PM, Gibrin WJ, Douglas DM: Transient, Nonpigmenting fixed drug eruption caused by radiopaque contrast media. J Am Acad Dermatol 23: 379-381, 1990
-
(1990)
J Am Acad Dermatol
, vol.23
, pp. 379-381
-
-
Benson, P.M.1
Gibrin, W.J.2
Douglas, D.M.3
-
5
-
-
2442710240
-
-
Japanese source
-
-
-
-
6
-
-
2442659057
-
-
Clin Neurosci 10 : 758-759, 1992
-
(1992)
Clin Neurosci
, vol.10
, pp. 758-759
-
-
-
7
-
-
0023644247
-
Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function associated antigen-1 (LFA-1)
-
Marlin SD, Springer TA: Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function associated antigen-1 (LFA-1). Cell 51: 813-819, 1987
-
(1987)
Cell
, vol.51
, pp. 813-819
-
-
Marlin, S.D.1
Springer, T.A.2
-
8
-
-
0025572708
-
Recognition by ELAM - 1 of the sialyl - Lex determinant on myeloid and tumor cells
-
Walz G, Aruffo A, Kolanus W, et al: Recognition by ELAM - 1 of the sialyl - Lex determinant on myeloid and tumor cells. Science 250: 1132-1135, 1990
-
(1990)
Science
, vol.250
, pp. 1132-1135
-
-
Walz, G.1
Aruffo, A.2
Kolanus, W.3
-
9
-
-
0025161990
-
VCAM-1 on activated endothelium znteracts with leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
-
Elices MJ, Osborn L, Takada Y, et al: VCAM-1 on activated endothelium znteracts with leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60: 577-584, 1990
-
(1990)
Cell
, vol.60
, pp. 577-584
-
-
Elices, M.J.1
Osborn, L.2
Takada, Y.3
-
10
-
-
0002718879
-
Vascular endothelial dysfunction and the pathogenesis of atherosclerosis
-
Waber PC, Leaf A ed: Raven Press, New York
-
Giimbrone MAJ, Kume N, Cybulsky MI: Vascular endothelial dysfunction and the pathogenesis of atherosclerosis. Waber PC, Leaf A ed: Atherosclerosis Reviews Vol. 25. 1-9, 1993, Raven Press, New York
-
(1993)
Atherosclerosis Reviews
, vol.25
, pp. 1-9
-
-
Giimbrone, M.A.J.1
Kume, N.2
Cybulsky, M.I.3
-
11
-
-
0026342111
-
Leukocyte Endothelial Cell Recognition: Three (or More) Steps to Specificity and Diversity
-
Butcher EC: Leukocyte Endothelial Cell Recognition: Three (or More) Steps to Specificity and Diversity. Cell 67: 1033-1036, 1991
-
(1991)
Cell
, vol.67
, pp. 1033-1036
-
-
Butcher, E.C.1
-
12
-
-
0024477696
-
Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factor
-
Griffiths CEM, Voorhees JJ, Nickoloff BJ: Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20: 617-629, 1989
-
(1989)
J Am Acad Dermatol
, vol.20
, pp. 617-629
-
-
Griffiths, C.E.M.1
Voorhees, J.J.2
Nickoloff, B.J.3
-
15
-
-
0017167355
-
Activation of the alternative pathway of the complement system by radiographic contrast media
-
Arroyabe CM, Bhat KN, Crown R: Activation of the alternative pathway of the complement system by radiographic contrast media. J Immunol 117: 1866-1869, 1976
-
(1976)
J Immunol
, vol.117
, pp. 1866-1869
-
-
Arroyabe, C.M.1
Bhat, K.N.2
Crown, R.3
-
16
-
-
0019180608
-
In vivo activation of serum complement by contrast media: A clinical study
-
Gonsette RE, Delmotte P: In vivo activation of serum complement by contrast media: a clinical study. Invest Radiol 15: 26-28, 1980
-
(1980)
Invest Radiol
, vol.15
, pp. 26-28
-
-
Gonsette, R.E.1
Delmotte, P.2
-
17
-
-
0025300146
-
Assays for plasma complement activation by X-ray contrast media
-
Eaton S, Tsay HM, Yost F,et al: Assays for plasma complement activation by X-ray contrast media. Invest Radiol 25: 789-792, 1990
-
(1990)
Invest Radiol
, vol.25
, pp. 789-792
-
-
Eaton, S.1
Tsay, H.M.2
Yost, F.3
-
18
-
-
0029436748
-
Complement activation and histamine release following administration of roentgen contrast media
-
Vik H, Frøysa A, Sønstevold A, et al: Complement activation and histamine release following administration of roentgen contrast media. Acta Radiol 36: 83-89, 1995
-
(1995)
Acta Radiol
, vol.36
, pp. 83-89
-
-
Vik, H.1
Frøysa, A.2
Sønstevold, A.3
-
19
-
-
0018101087
-
Activation of complement by radiographic contrast media. Generation of chemotactic and anaphylatoxin activities
-
Till G, Rother U, Gemsa D: Activation of complement by radiographic contrast media. Generation of chemotactic and anaphylatoxin activities. Int Archs Allerg appl Immun 56: 543-550, 1978
-
(1978)
Int Archs Allerg Appl Immun
, vol.56
, pp. 543-550
-
-
Till, G.1
Rother, U.2
Gemsa, D.3
-
20
-
-
2442685454
-
-
cyclic AMP 43 : 1114-1130, 1983
-
(1983)
Cyclic AMP
, vol.43
, pp. 1114-1130
-
-
-
21
-
-
0023555531
-
Pretreatment with corticosteroids to prevent reactions to i.v. contrast material: Overview and implications
-
Lasser EC: Pretreatment with corticosteroids to prevent reactions to i.v. contrast material: overview and implications. AJR 150: 257-259, 1988
-
(1988)
AJR
, vol.150
, pp. 257-259
-
-
Lasser, E.C.1
-
22
-
-
0014681825
-
Human C'3: Evidence for the liver as the primary site of synthesis
-
Alper CA, Johnson AM, Birtch AG, et al: Human C'3: evidence for the liver as the primary site of synthesis. Science 163: 286-288, 1969
-
(1969)
Science
, vol.163
, pp. 286-288
-
-
Alper, C.A.1
Johnson, A.M.2
Birtch, A.G.3
-
23
-
-
0023194091
-
Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro
-
Ueki A, Sai T, Oka H, et al: Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro. Immunology 61: 11-14, 1987
-
(1987)
Immunology
, vol.61
, pp. 11-14
-
-
Ueki, A.1
Sai, T.2
Oka, H.3
-
24
-
-
2442657837
-
-
Japanese source
-
-
-
-
25
-
-
2442637712
-
-
Japanese source
-
-
-
-
26
-
-
2442671583
-
-
Japanese source
-
-
-
-
27
-
-
0024587910
-
Whole body autoradiographic distribution studies on nonionic X-ray contrast agents in pregnant rats
-
Traenzer V, Wende S ed: Thieme Medical Publishers Inc. Stuttgart New York
-
Täuber U, Mutzel W, Schulze PE: Whole body autoradiographic distribution studies on nonionic X-ray contrast agents in pregnant rats. Traenzer V, Wende S ed: Recent Development in Nonionic Contrast Media. 215-219, 1989. Thieme Medical Publishers Inc. Stuttgart New York
-
(1989)
Recent Development in Nonionic Contrast Media
, pp. 215-219
-
-
Täuber, U.1
Mutzel, W.2
Schulze, P.E.3
-
28
-
-
0024521748
-
A large trial of Conray 325 and Niopan 300 to assess immediate and delayed reactions
-
McCullough M, Davis P, Richardson R, et al: A large trial of Conray 325 and Niopan 300 to assess immediate and delayed reactions. Brit J Radiol 622: 260-265, 1989
-
(1989)
Brit J Radiol
, vol.622
, pp. 260-265
-
-
McCullough, M.1
Davis, P.2
Richardson, R.3
-
29
-
-
2442702877
-
-
Japanese source
-
-
-
-
30
-
-
0028303562
-
The etiology of contrast medium reactions
-
Almen T: The etiology of contrast medium reactions. Invest Radiol 29 (Suppl. 1), 37-45, 1994
-
(1994)
Invest Radiol
, vol.29
, Issue.1 SUPPL.
, pp. 37-45
-
-
Almen, T.1
-
31
-
-
2442705359
-
-
Innervision 11 : 39-43, 1996
-
(1996)
Innervision
, vol.11
, pp. 39-43
-
-
-
32
-
-
0030058891
-
Biochemical Characterization of X-ray Contrast Media
-
Krause W, Niehues D : Biochemical Characterization of X-ray Contrast Media. Invest Radiol 31. 30-42, 1996
-
(1996)
Invest Radiol
, vol.31
, pp. 30-42
-
-
Krause, W.1
Niehues, D.2
|